Patent · US Active

Therapeutic agents

US10703794B2 · kind B2 · utility

2Cited by
6References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 28, 2016
Grant dateJul 7, 2020
Priority date
Expiry dateMar 10, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunoresponsive cell, such as a T-cell expressing This arrangement is referred to as parallel chimeric activating receptors (pCAR). Cells of this type are useful in therapy, and kits and methods for using them as well as methods for preparing them are described and claimed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.